ELI LILLY AND COMPANY LIMITED
UK registered
Companies House number 00284385·16 UK shareholdings·1 ownership layers
ELI LILLY AND COMPANY LIMITED is a UK-registered corporate shareholder (Companies House number 00284385) and holds shares in 16 active UK companies, recorded across 18 share-class positions on their Companies House confirmation statements (CS01). Beneath those direct holdings OpenRegistry resolves a further 0 companies spanning 1 ownership layers; the persons-with-significant-control register independently agrees on 2 of these holdings. It ranks #599 of 54,210 corporate shareholders by number of active UK holdings. Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.
Identity
UK company 00284385
Jurisdiction
UNITED KINGDOM
PSC register agrees on
2 holdings
Shareholdings
Every company ELI LILLY AND COMPANY LIMITED appears on as a member, as filed. 16 of 16 are linked to their Companies House profile.
| Company held | Status | Accounts | Share class | Shares | % of class | % of capital | Total % of capital | As of |
|---|
| VIANAUTIS BIO LIMITED11617905 | Active | TOTAL EXEMPTION FULL | SERIES A1 PREFERRED | 115,360 | | 9.05% | 9.05% | 2024-10-10 |
| TRIMTECH THERAPEUTICS LIMITED15299951 | Active | SMALL | SEED PREFERRED 1 | 228,571 | 7.62% | 5.59% | 5.59% | 2025-11-20 |
| MAXION THERAPEUTICS LIMITED12560803 | Active | SMALL | SERIES A | 425,194 | 8.33% | 5.08% | 5.08% | 2026-05-10 |
| AMPHISTA THERAPEUTICS LIMITED11119959 | Active | GROUP | SERIES B PREFERRED | 533,332 | 3.49% | 2.16% | 2.16% | 2025-12-06 |
| MINA (HOLDINGS) LIMITED09293168 | Active | GROUP | A1 PREFERRED | 186,916 | 84.62% | 0.25% | 0.25% | 2025-11-03 |
| BENEVOLENTAI LIMITED09781806 | Active | GROUP | ORDINARY | 0 | 0.00% | 0.00% | | 2022-10-15 |
| ELANCO ANIMAL HEALTH UK LIMITED02703014 | Active | DORMANT | ORDINARY | 0 | | | | 2025-04-01 |
| IMMUNOCORE LIMITED06456207 | Active | FULL | ORDINARY | 0 | | | | 2021-12-18 |
| SERIES A | 0 | | |
| SERIES B | 0 | | |
| APARITO LIMITED09285366 | Active | TOTAL EXEMPTION FULL | ORDINARY | 216,008 | | | | 2024-10-28 |
| EVOX THERAPEUTICS LIMITED10076821 | Active | FULL | B PREFERRED | 23,791 | | | | 2026-03-16 |
| SITRYX THERAPEUTICS LIMITED10366466 | Active | GROUP | SERIES A PREFERRED SHARES | 8,024,263 | | | | 2025-09-07 |
| NANOSYRINX LTD11595354 | Active | UNAUDITED ABRIDGED | SEED ORDINARY | 462,962 | | | | 2026-03-16 |
| MYRICX PHARMA LIMITED12082645 | Active | SMALL | SERIES A SHARES | 2,234,636 | | | | 2025-07-02 |
| ALCHEMAB THERAPEUTICS LTD12156844 | Active | MEDIUM | SERIES A-2 PREFERRED | 7,925,046 | | | | 2025-11-28 |
| LAVEROCK THERAPEUTICS LIMITED13508159 | Active | SMALL | C ORDINARY | 737,101 | | | | 2025-07-12 |
| MIRONID LIMITEDSC476430 | Active | SMALL | ORDINARY CLASS B SHARES | 4,202 | | | | 2023-09-20 |
Related company owners
Corporate shareholders that hold shares in the same UK companies as ELI LILLY AND COMPANY LIMITED:
Other corporate shareholders of comparable size registered in UNITED KINGDOM:
Need the registered office, SIC code, accounts and filing history for ELI LILLY AND COMPANY LIMITED? Open its Companies House profile at https://openregistry.sophymarine.com/insights/gb/00284385-eli-lilly-and-company-limited.